Alcidion Group Limited (ALC)
CXA 
Summary
Is it Apt to Retain Alcon Stock in Your Portfolio for Now?
ALC stays on investors' radar due to its Vision Care arm's performance and contributions from new products despite macro risks and stiff competition.
Alcon Canada Earns Global Recognition as a Top Employer
TORONTO--(BUSINESS WIRE)-- #AlconCanada--Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced that Alcon Canada has been certified as a Top Employer in Canada by the Top Employers Institute, a recognized authority on identifying excellence in people practices and workplace culture. Being certified as a Top Employer showcases Alcon Canada's commitment to building a better world of work through exceptional HR policies and forward-thinking people practices. This recog.
Gordon Schanzlin New Vision Institute Becomes First U.S. Clinic to Use Alcon's Breakthrough Unity Phaco System
Dr. Echegoyen Participated in Clinical Trials for the First Major Phacoemulsification Advancement in Over 15 Years Dr. Echegoyen Participated in Clinical Trials for the First Major Phacoemulsification Advancement in Over 15 Years
Alcidion Group Limited Dividends
| ALC In 10 months Estimated | Annual | $0.33 Per Share |
| ALC 1 month ago Paid | Annual | $0.33 Per Share |
| ALC 14 May 2024 Paid | Annual | $0.26 Per Share |
| ALC 10 May 2023 Paid | Annual | $0.24 Per Share |
| ALC 3 May 2022 Paid | Annual | $0.2 Per Share |
| ALC 4 May 2021 Paid | Annual | $0.11 Per Share |
Alcidion Group Limited Earnings
| 20 Aug 2025 (In 1 month) Date | | 0.72 Cons. EPS | - EPS |
| 8 May 2025 Date | | 0.76 Cons. EPS | 0.73 EPS |
| 25 Feb 2025 Date | | 0.72 Cons. EPS | 0.72 EPS |
| 12 Nov 2024 Date | | 0.74 Cons. EPS | 0.53 EPS |
| 20 Aug 2024 Date | | 0.73 Cons. EPS | 0.74 EPS |
| ALC In 10 months Estimated | Annual | $0.33 Per Share |
| ALC 1 month ago Paid | Annual | $0.33 Per Share |
| ALC 14 May 2024 Paid | Annual | $0.26 Per Share |
| ALC 10 May 2023 Paid | Annual | $0.24 Per Share |
| ALC 3 May 2022 Paid | Annual | $0.2 Per Share |
| ALC 4 May 2021 Paid | Annual | $0.11 Per Share |
| 20 Aug 2025 (In 1 month) Date | | 0.72 Cons. EPS | - EPS |
| 8 May 2025 Date | | 0.76 Cons. EPS | 0.73 EPS |
| 25 Feb 2025 Date | | 0.72 Cons. EPS | 0.72 EPS |
| 12 Nov 2024 Date | | 0.74 Cons. EPS | 0.53 EPS |
| 20 Aug 2024 Date | | 0.73 Cons. EPS | 0.74 EPS |
Alcidion Group Limited (ALC) FAQ
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
What is the earnings per share?
When is the next earnings date?
Has Alcidion Group Limited ever had a stock split?
Alcidion Group Limited Profile
| Medical - Instruments & Supplies Industry | Healthcare Sector | David J. Endicott CEO | CXA Exchange | CH0432492467 ISIN |
| CH Country | 25,599 Employees | 14 May 2025 Last Dividend | - Last Split | - IPO Date |
Overview
Alcon Inc. is a global leader in eye care, specializing in the research, development, manufacturing, distribution, and sales of a wide range of eye care products. Catering to both eye care professionals and patients, Alcon's mission is to enhance vision and improve people's lives through innovative products and solutions. The company's portfolio spans across surgical procedures and vision care, addressing a broad spectrum of eye health needs. Originally founded in 1945 as Alcon Universal S.A., the company underwent a name change to Alcon Inc. in December 2001 and has since established its headquarters in Geneva, Switzerland, marking its presence as a key player in the eye care industry on a global scale.
Products and Services
Alcon Inc.'s offerings are divided into two main segments: Surgical and Vision Care, each catering to distinct aspects of eye health and surgery.
- Surgical Segment:
- Vision Care Segment:
Within the surgical field, Alcon provides a comprehensive array of products including equipment, instrumentation, diagnostics, intraocular lenses (IOLs), and other implantables, along with various consumables. These specialized products support a wide range of procedures from cataract surgery to vitreoretinal operations. Notable products within this segment include the Centurion Vision System, LenSx Laser System for cataract treatment, Constellation Vision Systems for vitreoretinal surgeries, and the WaveLight Lasers for LASIK treatments. Additionally, Alcon offers innovative solutions like the NGENUITY 3D Visualization System and the ORA system for enhanced surgical precision and outcomes. Custom surgical packs and a variety of manual surgical instruments further complement Alcon’s surgical offerings.
Alcon’s Vision Care segment focuses on enhancing daily eye health and visual comfort through a wide range of products. This includes daily disposable, reusable, and color-enhancing contact lenses designed to meet diverse needs and preferences. Beyond corrective lenses, Alcon provides solutions for common eye concerns such as dry eye, ocular allergies, and glaucoma, as well as products for contact lens care. The segment is also home to ocular vitamins and redness relievers, aimed at maintaining overall eye health and comfort.
Contact Information
